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Introduction
Proteus mirabilis (P. mirabilis) is a species of Gram-negative and 
facultative anaerobic bacteria that shows swarming motility and urease 
activity. Proteus ranked third as the cause of hospital-acquired infections 
[1]. The organism is rod-shaped and motile bacterium with diverse 
mode of transmission [2]. P. mirabilis is a common causative organism 
of urinary tract infection (UTI) in the complicated urinary tract, 
most frequently in patients with the indwelling catheters or structural 
abnormalities of the urinary tract [3]. It expresses various virulence 
factors which are involved in uropathogenesis like adhesins (i.e., PMP 
fimbriae), motility (i.e., flagella) toxins (i.e., hemolysin and Proteus 
toxic agglutinin), quorum-sensing (i.e., cell-cell communication), 
enzymes (i.e., urease) and immune invasion (i.e., metalloproteinase 
- ZapA) [4]. The infection is more prone to male than female [5]. In 
hospitals, it is the second most frequently isolated Enterobacteriaceae 
species after Escherichia coli. The wild-type isolates of this species are 
more susceptible to β-lactams antimicrobials [6]. The organism possess 
a black-brown colour pigment, which behaves like a melanin in many 
respects, such as solubility, bleaching by oxidizing agents and positive 
response to the Fontana-Masson assay [7]. Most types of antibiotics 
are sensitive to P. mirabilis such as penicillin’s, cephalosporins, 
aminoglycosides, refamycin, fluoroquinolones, and phenicols while 
resistant to amoxicillin, cefotaxime and carbenicillin [8,9]. 
Therefore, an alternative strategy is needed against P. mirabilis 
infection. Biofield treatment has been known and popularized as an 
alternative approach that may be useful for the assessment of sensitivity 
profile of the organism [10-12]. 
The human body can emits the electromagnetic waves in the form 
of bio-photons, which surrounds the body and it is commonly known 
as biofield. Therefore, the biofield can generate by moving electrically 
charged particles (ions, cell, molecule, etc.) inside the human body. 
According to Rivera-Ruiz et al., it was reported that electrocardiography 
has been extensively used to measure the biofield of human body [13]. 
Thus, human has the ability to harness the energy from environment or 
universe and can transmit into any living or nonliving object(s) around 
the Globe. The objects always receive the energy and responding into 
useful way that is called biofield energy and the process is known as 
biofield treatment. Biofield (putative energy fields) or electromagnetic 
based energy therapies, used to promote health and healing had been 
exclusively reported by National Institute of Health/National Center 
for Complementary and Alternative Medicine (NIH/NCCAM) [14]. 
Mr. Trivedi’s unique biofield treatment (The Trivedi Effect®) has been 
known to transform the structural, physical and thermal properties 
of several metals and ceramic in materials science [15-17], improved 
the overall productivity of crops [18,19], and improved growth and 
anatomical characteristics of medicinal plants [20,21].
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Due to the clinical significance of this organism and literature 
reports on biofield treatment, the present work was undertaken to 
evaluate the impact of biofield treatment on P. mirabilis in relation to 
their antimicrobials susceptibility, biochemical reaction, and biotyping. 
Materials and Method
P. mirabilis, American Type Culture Collection (ATCC 25933) 
strain was procured from MicroBioLogics, Inc., USA and stored with 
proper storage conditions until further use. All the tested antimicrobials 
and biochemicals were procured from Sigma-Aldrich (MA, USA). The 
antimicrobial susceptibility, biochemical reactions and biotype number 
were estimated with the help of MicroScan Walk-Away® (Dade Behring 
Inc., West Sacramento, CA, USA) using Negative Breakpoint Combo 30 
(NBPC 30) panel with respect to control group (Gr.). 
Study Design
Two ATCC 25933 samples A and B of P. mirabilis were grouped 
(Gr.). ATCC A sample was revived and divided into two parts named as 
Gr.I (control) and Gr.II (revived, treated); likewise, ATCC B was labeled 
as Gr.III (lyophilized, treated). 
Biofield Treatment Strategy
Mr. Trivedi provided the biofield treatment through his energy 
transmission process to the treated groups without touching the 
samples. In this process energy is transferred to the absorbing medium 
(sealed microbial samples) and this may cause several changes to occur 
within the absorbing medium. The treated samples were assessed for 
the antimicrobial sensitivity, biochemical reactions, and biotyping as 
per experimental design. Whilst handing over these cultures to Mr. 
Trivedi for retreatment purposes, optimum precautions were taken to 
avoid contamination. 
Antimicrobial Susceptibility Test
Investigation of antimicrobial susceptibility of P. mirabilis was 
carried out with the help of automated instrument, MicroScan Walk-
Away® using NBPC 30 panel. The panel can be stored at 2 to 25°C for 
analysis. The panel was allowed to equilibrate to room temperature prior 
to rehydration. The tests carried out on MicroScan were miniaturized of 
the broth dilution susceptibility test that has been dehydrated. Briefly, 
the 0.1 mL of the standardized suspension of P. mirabilis was pipetted 
into 25 mL of inoculum water using pluronic and inverted 8 to 10 times 
and inoculated, rehydrated, and then subjected to incubation for 16 
hours at 35°C. Rehydration and inoculation was performed using the 
RENOK® system with inoculators-D (B1013-4). 25 mL of standardized 
inoculum suspension was poured in to inoculum tray. The detailed 
experimental procedure and conditions were followed as per the 
manufacturer's instructions. MIC is defined as the lowest concentration 
of an antimicrobial that inhibits the visible growth of a microorganism 
after overnight incubation. The antimicrobial susceptibility pattern (S: 
Susceptible, R: Resistant; and I: Intermediate) and minimum inhibitory 
concentration (MIC) values were determined by observing the lowest 
antimicrobial concentration showing inhibition of growth [22]. 
Biochemical Reaction Studies
Biochemical reactions of P. mirabilis were determined using 
MicroScan Walk-Away®, system with NBPC 30 panel. The preparation 
of NBPC 30 panel, inoculum followed by dehydration and rehydration 
was performed similar way as mentioned in antimicrobial susceptibility 
assay for analysis of biochemical reaction followed by biotype number. 
The detailed experimental procedures and conditions were followed as 
per the manufacturer's instructions [22].
Identification of Organism by Biotype Number 
The biotype number of P. mirabilis was determined on MicroScan 
Walk-Away® processed panel data report with the help of biochemical 
reactions data [22].
Results and Discussion
Antimicrobial susceptibility test
The result of P. mirabilis susceptibility pattern and MIC values of 
tested antimicrobials after biofield energy treatment are summarized 
in Tables 1 and 2, respectively. The data were analyzed and compared 
with respect to the control (Gr. I). Study was carried out with thirty 
antimicrobials. Overall, the treated cells of P. mirabilis showed 6.67% 
alteration in antimicrobial sensitivity pattern as compared to the 
control. P. mirabilis was the common species causes majority of Proteus 
infections followed by P. vulgaris, and P. penneri. The Proteus isolates 
were generally susceptible to gentamicin, amikacin, ceftriaxone, 
cefuroxime and cefotaxime. The control data were well matched with 
literature [23]. The ampicillin sensitivity was converted from susceptible 
(S) to intermediate (I) with increase of MIC value by two-fold (≤ 8 to 
Table 1: Antibiogram of Proteus mirabilis: Effect of biofield treatment on 
antimicrobial susceptibility.
S. No. Antimicrobial Type of Response
Gr. I Gr. II Gr. III 
(Day 10)Day 5 Day 10
1. Amikacin S S S S
2. Amoxicillin/k-clavulanate S S S S
3. Ampicillin/sulbactam S S S S
4. Ampicillin S S I S
5. Aztreonam S S S S
6. Cefazolin S S S S
7. Cefepime S S S S
8. Cefotaxime S S S S
9. Cefotetan S S S S
10. Cefoxitin S S S S
11. Ceftazidime S S S S
12. Ceftriaxone S S S S
13. Cefuroxime S S S S
14. Cephalothin S I S S
15. Chloramphenicol S S S S
16. Ciprofloxacin S S S S
17. Gatifloxacin S S S S
18. Gentamicin S S S S
19. Imipenem S S S S
20. Levofloxacin S S S S
21. Meropenem S S S S
22. Moxifloxacin S S S S
23. Nitrofurantoin S S S S
24. Norfloxacin S S S S
25. Piperacillin/Tazobactam S S S S
26. Piperacillin S S S S
27. Tetracycline R R R R
28. Ticarcillin/k-clavulanate S S S S
29. Tobramycin S S S S
30. Trimethoprim/sulfamethoxazole S S S S
R: Resistant; S: Susceptible; I: Intermediate; Gr.: Group 
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16 µg/mL) in Gr. II on day 10 as compared to the untreated group. In 
additionally, cephalothin was converted from S to I with increase of 
MIC value by two-fold (≤ 8 to 16 µg/mL) in Gr. II on day 5 as compared 
to the Gr. I. The decrease susceptibility and increase MIC value were 
well supported with literature [24]. The susceptibility and MIC data of 
both antibiotics ampicillin and cephalothin were well correlated in this 
experiment. The MIC value of nitrofurantoin was slightly increased 
in Gr. II on day 10 as compared to the control. Overall, the treated 
cells of P. mirabilis showed 9.38% alteration in MIC values of tested 
antimicrobials. Rest of the antimicrobials did not show any alteration 
in terms of antimicrobial susceptibility and MIC values as compared 
to control. 
Biochemical reactions studies
The study of biochemical reactions can be utilized to identify 
the enzymatic and metabolic characteristic features of microbes. 
Microorganisms can be categorically differentiated based on their 
utilization of specific biochemicals as nutrients during the process of 
metabolism or enzymatic reactions. Table 3 shows the conventional 
biochemical tests necessary for the differentiation of P. mirabilis. The 
tested biochemicals such as adonitol (ADO), arabinose (ARA), esculin 
hydrolysis (ESC), nitrofurantoin (FD64), kanamycin (K4), lysine (LYS), 
malonate (MAL), melibiose (MEL), raffinose (RAF), rhamnose (RHA), 
sorbitol (SOR), and sucrose (SUC) were  converted from negative (-) 
to positive (+) reaction in revived treated group (Gr. II) on day 10, 
as compared to the control. However, it did not show any change in 
others groups. Cephalothin was converted from negative (-) to positive 
(+) reaction in revived treated group (Gr. II) on day 5, while did not 
produce any effect on others treated samples as compared to the control. 
Moreover, penicillin showed positive (+) reaction in Gr. II (both days 5 
and 10), while did not show any response in lyophilized treated group 
(Gr. III) as compared to the control (i.e., negative reaction). Overall, 
the treated cells of P. mirabilis showed 42.42% alteration in biochemical 
reaction pattern of tested antimicrobials. Based on literature there was 
two types of reaction phenomenon of indole, i.e., indole positive P. 
mirabilis and indole negative P. mirabilis [25]. In this experiment based 
on the findings of biochemical reaction it is assumed that the strain is 
indole negative. Rest of the biochemicals did not show any alteration 
of biochemical reactions in all the treated groups as compared to the 
control (Table 3).
Table 2: Effect of biofield treatment on Proteus mirabilis to minimum inhibitory 
concentration (MIC) value of tested antimicrobials.
 S. No. Antimicrobial Type of Response
Gr. I Gr. II Gr. III
(Day 10)Day 5 Day 10
1. Amikacin ≤ 16 ≤ 16 ≤ 16 ≤ 16
2. Amoxicillin/k-clavulanate ≤ 8/4 ≤ 8/4 ≤ 8/4 ≤ 8/4
3. Ampicillin/sulbactam ≤ 8/4 ≤ 8/4 ≤ 8/4 ≤ 8/4
4. Ampicillin ≤ 8 ≤8 16 ≤ 8
5. Aztreonam ≤ 8 ≤8 ≤ 8 ≤ 8
6. Cefazolin ≤ 8 ≤ 8 ≤ 8 ≤ 8
7. Cefepime ≤ 8 ≤ 8 ≤ 8 ≤ 8
8. Cefotaxime ≤ 8 ≤ 8 ≤ 8 ≤ 8
9. Cefotetan ≤ 16 ≤ 16 ≤ 16 ≤ 16
10. Cefoxitin ≤ 8 ≤ 8 ≤ 8 ≤ 8
11. Ceftazidime ≤ 8 ≤ 8 ≤ 8 ≤ 8
12. Ceftriaxone ≤ 8 ≤ 8 ≤ 8 ≤ 8
13. Cefuroxime ≤ 4 ≤ 4 ≤ 4 ≤ 4
14. Cephalothin ≤ 8 16 ≤ 8 ≤ 8
15. Chloramphenicol ≤ 8 ≤ 8 ≤ 8 ≤ 8
16. Ciprofloxacin ≤ 1 ≤ 1 ≤ 1 ≤ 1
17. ESBL-a Scrn ≤ 4 ≤ 4 ≤ 4 ≤ 4
18. ESBL-b Scrn ≤ 1 ≤ 1 ≤ 1 ≤ 1
19. Gatifloxacin ≤ 2 ≤ 2 ≤ 2 ≤ 2
20. Gentamicin ≤ 4 ≤ 4 ≤ 4 ≤ 4
21. Imipenem ≤ 4 ≤ 4 ≤ 4 ≤ 4
22. Levofloxacin ≤ 2 ≤ 2 ≤ 2 ≤ 2
23. Meropenem ≤ 4 ≤ 4 ≤ 4 ≤ 4
24. Moxifloxacin ≤ 2 ≤ 2 ≤ 2 ≤ 2
25. Nitrofurantoin 64 64 >64 64
26. Norfloxacin ≤ 4 ≤ 4 ≤ 4 ≤ 4
27. Piperacillin/tazobactam ≤ 16 ≤ 16 ≤ 16 ≤ 16
28. Piperacillin ≤ 16 ≤ 16 ≤ 16 ≤ 16
29. Tetracycline >8 >8 >8 >8
30. Ticarcillin/k-clavulanate ≤ 16 ≤ 16 ≤ 16 ≤ 16
31. Tobramycin ≤ 4 ≤ 4 ≤ 4 ≤ 4
32. Trimethoprim/
sulfamethoxazole
≤ 2/38 ≤ 2/38 ≤ 2/38 ≤ 2/38
MIC data are presented in µg/mL; Gr.: Group; ESBL: Extended spectrum 
β-lactamase
Table 3: Effect of biofield treatment on Proteus mirabilis to the biochemical reaction 
pattern.
-, (negative); +, (positive); Gr.: Group
S. No. Code Biochemical Gr. I Type of Response
Gr. II Gr. III 
(Day 10)Day 5 Day 10
1. ACE Acetamide - - - -
2. ADO Adonitol - - + -
3. ARA Arabinose - - + -
4. ARG Arginine - - - -
5. CET Cetrimide - - - -
6. CF8 Cephalothin - + - -
7. CIT Citrate + + + +
8. CL4 Colistin + + + +
9. ESC Esculin hydrolysis - - + -
10. FD64 Nitrofurantoin - - + -
11. GLU Glucose + + + +
12. H2S Hydrogen sulfide + + + +
13. IND Indole - - - -
14. INO Inositol - - - -
15. K4 Kanamycin - - + -
16. LYS Lysine - - + -
17. MAL Malonate - - + -
18. MEL Melibiose - - + -
19. NIT Nitrate + + + +
20. OF/G Oxidation-fermentation/glucose + + + +
21. ONPG Galactosidase - - - -
22. ORN Ornithine + + + +
23. OXI Oxidase - - - -
24. P4 Penicillin + + + -
25. RAF Raffinose - - + -
26. RHA Rhamnose - - + -
27. SOR Sorbitol - - + -
28. SUC Sucrose - - + -
29. TAR Tartrate - - - -
30. TDA Tryptophan deaminase + + + +
31. TO4 Tobramycin - - - -
32. URE Urea + + + +
33. VP Voges-Proskauer + + + +
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Identification of organism by biotype number 
The species (P. mirabilis) was identified based on variety of 
conventional biochemical characters and biotyping. Biotype number of 
particular organism was evaluated after interpreting the results of the 
biochemical reactions. The biotype number then led to the particular 
organism identification. In this experiment, biotyping was performed 
using automated systems, and results showed significant change in 
biotype number (77365764) in the biofield treated Gr. II (on day 10) as 
compared to control Gr. I (40061544). Although, the organism was not 
altered after biofield energy treatment. The biotype number was also 
changed in Gr. II on day 5 (40061546) as compared to the control. Rest 
of the group (Gr. III) did not show any alteration of biotype number 
after biofield energy treatment as compared to their respective control 
(Table 4).
Biofield treatment might be responsible for alteration in 
microorganism at enzymatic and/or genetic level, which may act on 
receptor protein. While altering receptor protein, ligand-receptor/
protein interactions may altered that could lead to show different 
phenotypic characteristics [26]. Biofield treatment might induce 
significant changes in revived strain of P. mirabilis and altered 
antimicrobials susceptibility pattern, MIC values, biochemical reactions, 
which ultimately change the biotype number of microorganism. As a 
result, the microbe that was susceptible to a particular antimicrobial in 
control sample now converted into intermediate in the treated cells of P. 
mirabilis predominately after biofield energy treatment. 
In this experiment, the main objective was to see the impact of 
Mr. Trivedi’s biofield energy treatment on an opportunistic hospital 
acquired pathogen of P. mirabilis in in vitro. Based on the findings 
of antimicrobial susceptibility pattern of ampicillin and cephalothin 
showed that the susceptible nature of both control samples and it 
became intermediate on Gr. II. So far our group had been published 
many research articles regarding the effect biofield treatment on ATCC 
and multidrug resistant (MDR) strains [17-19]. Based on these results, 
it is expected that biofield treatment has the scope to be an alternative 
approach than the existing antimicrobial therapy in near future.
Conclusion
Altogether, the biofield treatment showed 6.67% alteration in 
antimicrobial susceptibility pattern with 9.38% change in MIC values of 
tested antimicrobials against the strain of P. mirabilis. It also significantly 
altered the biochemical reactions pattern (42.42%) and biotype number 
of biofield treated strain of P. mirabilis. The biotype number was changed 
in the treated group II on day 5 (40061546) and on day 10 (77365764) 
as compare to the control (40061544) without alteration of microbes. 
Thus, Mr. Trivedi’s unique biofield energy treatment could be applied as 
alternative therapeutic approach against antimicrobials in future.
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